אנגריד 0.5
rafa laboratories ltd - anagrelide as hydrochloride - קפסולות - anagrelide as hydrochloride 0.5 mg - anagrelide - anagrelide - treatment for essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.
גליקסמבי 10 מג 5 מג
boehringer ingelheim israel ltd. - empagliflozin; linagliptin - טבליות מצופות פילם - linagliptin 5 mg; empagliflozin 10 mg - linagliptin and empagliflozin
גליקסמבי 25 מג 5 מג
boehringer ingelheim israel ltd. - empagliflozin; linagliptin - טבליות מצופות פילם - linagliptin 5 mg; empagliflozin 25 mg - linagliptin and empagliflozin
דרונאביר טבע 800 מג
teva pharmaceutical industries ltd, israel - darunavir - טבליות מצופות פילם - darunavir 800 mg - darunavir
דרונאביר טבע 600 מג
teva pharmaceutical industries ltd, israel - darunavir - טבליות מצופות פילם - darunavir 600 mg - darunavir
פוזיד
teva pharmaceutical industries ltd, israel - furosemide - טבליה - furosemide 40 mg - furosemide - furosemide - edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. adjunctive therapy in acute pulmonary edema. treatment of hypertension.
קרוודילול טבע 6.25 מג
teva israel ltd - carvedilol - טבליה - carvedilol 6.25 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.
קרוודילול טבע 12.5 מג
teva israel ltd - carvedilol - טבליה - carvedilol 12.5 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.
אוויסטה
eli lilly israel ltd, israel - raloxifene hydrochloride - טבליות מצופות פילם - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.
סוליפנאצין טבע 5 מג
teva pharmaceutical industries ltd, israel - solifenacin succinate - טבליה - solifenacin succinate 5 mg - solifenacin - solifenacin - solifenacin is indicated for symptomatic treatment of urge incontinence and/or urinary frequency and urgency as may occur in patients with overactive bladder syndrome.